Macquarie Group LTD Haleon PLC Transaction History
Macquarie Group LTD
- $86.4 Billion
- Q4 2024
A detailed history of Macquarie Group LTD transactions in Haleon PLC stock. As of the latest transaction made, Macquarie Group LTD holds 1,352 shares of HLN stock, worth $14,425. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,352
Previous 911
48.41%
Holding current value
$14,425
Previous $9,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding HLN
# of Institutions
662Shares Held
432MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.91 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$350 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$257 Million1.6% of portfolio
-
Wellington Management Group LLP Boston, MA15.3MShares$164 Million0.03% of portfolio
-
Morgan Stanley New York, NY9.89MShares$106 Million0.01% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $49.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...